Pursuant to Regulation 30(6) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, the audio recording of the earnings call and earnings pr...

Proven Ability In Life Sciences

February 15, 2023

To, BSE Limited Corporate Relationship Department Phiroze Jeejeebhoy Towers, Dalal Street, Fort, Mumbai – 400 001

National Stock Exchange of India Limited Listing Department Exchange Plaza, Bandra-Kurla Complex, Bandra (East), Mumbai – 400 051

Scrip code: 512529

Symbol: SEQUENT

Subject: Audio Recording of Earnings call and Earnings presentation pertaining to the Unaudited Financial Results (Consolidated and Standalone) for the quarter and nine months ended December 31, 2022

Dear Sir/ Madam,

Pursuant to Regulation 30(6) of the Securities and Exchange Board of India (Listing Obligations and

Disclosure Requirements) Regulations, 2015, the audio recording of the earnings call and earnings

presentation made on February 15, 2023, on Unaudited Financial Results (Consolidated and

Standalone) of the Company for the quarter and nine months ended December 31, 2022, is available

on the Company’s website at:

https://sequent.in/pdf/financial/2022-2023/Q3/SEQ0220230215145059.mp3

Kindly take the same on your records.

Yours faithfully,

For Sequent Scientific Limited

Krunal Shah Company Secretary & Compliance Officer

Registered Office: 301, 3rd Floor, Dosti Pinnacle, Plot No. E7, Road No. 22, Wagle Industrial Estate, Thane (W), Mumbai - 400604, Maharashtra, India Tel No.: +91-22-4111-4777 I CIN: L99999MH1985PLC036685 Website: http://www.sequent.in I Email Id: investorrelations@sequent.in

SeQuent Scientific Limited